Alex Ochs will use his ISCRM fellowship to conduct a proof-of-concept computational modeling evaluation of whether subthreshold optogenetic stimulation to induce a weak repolarizing current could suppress engraftment arrhythmia. The goal is to validate a potential approach that could improve the safety and efficacy of stem cell therapy for heart attack victims.